title: Teriparatide Enhancement of Lumbar Fusion: Bone Enhancement Versus Cost, Convenience, and Risk of Cancer: Commentary on an article by Shigeto Ebata, MD, PhD, et al.: "Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders. A Multicenter, Prospective Randomized Study".
authors.affiliation: Denver Spine Surgeons, Greenwood Village, Colorado.
authors.forename: David A
authors.initials: DA
authors.lastname: Wong
mesh_terms: D006801:Humans; D008159:Lumbar Vertebrae; D008161:Lumbosacral Region; D009369:Neoplasms; D010024:Osteoporosis; D011446:Prospective Studies; D013123:Spinal Fusion; D019379:Teriparatide; D016896:Treatment Outcome
chemical_list: D019379:Teriparatide